These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROL PILOT STUDY OF EPLERENONE FOR THE TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY (ECSELSIOR). Rahimy E; Pitcher JD; Hsu J; Adam MK; Shahlaee A; Samara WA; Vander JF; Kaiser RS; Chiang A; Spirn MJ; Fineman MS Retina; 2018 May; 38(5):962-969. PubMed ID: 28426624 [TBL] [Abstract][Full Text] [Related]
45. [Eplerenone treatment in chronic central serous chorioretinopathy]. Sampo M; Soler V; Gascon P; Ho Wang Yin G; Hoffart L; Denis D; Matonti F J Fr Ophtalmol; 2016 Jun; 39(6):535-42. PubMed ID: 27230892 [TBL] [Abstract][Full Text] [Related]
46. Comparison of choroidal and optic nerve head blood flow regulation during changes in ocular perfusion pressure. Schmidl D; Boltz A; Kaya S; Werkmeister R; Dragostinoff N; Lasta M; Polska E; Garhöfer G; Schmetterer L Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4337-46. PubMed ID: 22661477 [TBL] [Abstract][Full Text] [Related]
47. Choriocapillaris flow features and choroidal vasculature in the fellow eyes of patients with acute central serous chorioretinopathy. Yun C; Huh J; Ahn SM; Lee B; Kim JT; Hwang SY; Kim SW; Oh J Graefes Arch Clin Exp Ophthalmol; 2019 Jan; 257(1):57-70. PubMed ID: 30397792 [TBL] [Abstract][Full Text] [Related]
48. Increased choroidal blood flow and choroidal thickness in patients with hypertensive chorioretinopathy. Saito M; Noda K; Saito W; Hirooka K; Hashimoto Y; Ishida S Graefes Arch Clin Exp Ophthalmol; 2020 Feb; 258(2):233-240. PubMed ID: 31724089 [TBL] [Abstract][Full Text] [Related]
49. Role of Psychological Stress and Choroidal Thickness in Central Serous Chorioretinopathy. Mathews R; Horo S; Jose D; Kavalakatt JA; J GR; John SS Nepal J Ophthalmol; 2023 Jul; 15(30):36-46. PubMed ID: 38976335 [TBL] [Abstract][Full Text] [Related]
51. CENTRAL SEROUS CHORIORETINOPATHY TREATED WITH MINERALOCORTICOID ANTAGONISTS: A ONE-YEAR PILOT STUDY. Ghadiali Q; Jung JJ; Yu S; Patel SN; Yannuzzi LA Retina; 2016 Mar; 36(3):611-8. PubMed ID: 26405766 [TBL] [Abstract][Full Text] [Related]
52. PATTERNS OF CHORIOCAPILLARIS FLOW SIGNAL VOIDS IN CENTRAL SEROUS CHORIORETINOPATHY: An Optical Coherence Tomography Angiography Study. Matet A; Daruich A; Hardy S; Behar-Cohen F Retina; 2019 Nov; 39(11):2178-2188. PubMed ID: 30028410 [TBL] [Abstract][Full Text] [Related]
53. Predictive factors of selective mineralocorticoid receptor antagonist treatment in chronic central serous chorioretinopathy. Gergely R; Kovács I; Récsán Z; Sándor GL; Czakó C; Nagy ZZ; Ecsedy M Sci Rep; 2020 Oct; 10(1):16621. PubMed ID: 33024222 [TBL] [Abstract][Full Text] [Related]
54. One-year outcome of cystoid macular degeneration in central serous chorioretinopathy. Kumar Sahoo N; Lupidi M; Goud A; Gangakhedkar S; Cardillo Piccolino F; Chhablani J Eur J Ophthalmol; 2022 Jul; 32(4):2347-2354. PubMed ID: 34615406 [TBL] [Abstract][Full Text] [Related]
55. Choroidal Anatomic Alterations After Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Multicenter Study. Iovino C; Au A; Chhablani J; Parameswarappa DC; Rasheed MA; Cennamo G; Cennamo G; Montorio D; Ho AC; Xu D; Querques G; Borrelli E; Sacconi R; Pichi F; Woodstock E; Sadda SR; Corradetti G; Boon CJF; van Dijk EHC; Loewenstein A; Zur D; Yoshimi S; Freund KB; Peiretti E; Sarraf D Am J Ophthalmol; 2020 Sep; 217():104-113. PubMed ID: 32360342 [TBL] [Abstract][Full Text] [Related]
56. En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy. Ferrara D; Mohler KJ; Waheed N; Adhi M; Liu JJ; Grulkowski I; Kraus MF; Baumal C; Hornegger J; Fujimoto JG; Duker JS Ophthalmology; 2014 Mar; 121(3):719-26. PubMed ID: 24289918 [TBL] [Abstract][Full Text] [Related]
57. Regulation of Choroidal Blood Flow During Isometric Exercise at Different Levels of Intraocular Pressure. Popa-Cherecheanu A; Schmidl D; Werkmeister RM; Chua J; Garhöfer G; Schmetterer L Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):176-182. PubMed ID: 30640970 [TBL] [Abstract][Full Text] [Related]
58. Efficacy of mineralocorticoid receptor antagonist for central serous chorioretinopathy: a meta-analysis. Zhang B; Chou Y; Zhao X; Yang J; Chen Y Int Ophthalmol; 2020 Nov; 40(11):2957-2967. PubMed ID: 32632615 [TBL] [Abstract][Full Text] [Related]
59. Macular microvascular changes in resolved central serous chorioretinopaty using spectral-domain optical coherence tomography angiography. Bahadir Akkoc S; Kazim Erol M; Suren E J Fr Ophtalmol; 2021 May; 44(5):693-702. PubMed ID: 33896657 [TBL] [Abstract][Full Text] [Related]
60. Choroidal hemodynamic in myopic patients with and without primary open-angle glaucoma. Samra WA; Pournaras C; Riva C; Emarah M Acta Ophthalmol; 2013 Jun; 91(4):371-5. PubMed ID: 22458651 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]